Oncology
🇺🇸 FDA Page 18FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 205–216 of 246 articles
Innate Pharma IPH5201 MATISSE Phase 2 Results Selected for AACR 2026 Clinical Trials Plenary Session
Accent Therapeutics ATX-295 Shows Promising Anti-Cancer Activity in Preclinical Studies at AACR 2026
Olema Oncology Presents Palazestrant and OP-3136 Preclinical Data at AACR 2026 for Breast Cancer Treatment
Nuvalent's Zidesamtinib Shows Promise in ROS1-Positive Lung Cancer Patients at AACR 2026
FDA Approves IMGN-901: Breakthrough Therapy for Relapsed/Refractory AML
MAIA Biotechnology Activates First U.S. Site for Phase 2 Telomere-Targeting NSCLC Treatment Trial
Boehringer Ingelheim's Zongertinib Shows Promise for HER2-Mutant Lung Cancer in NEJM Study
FDA Approves CancerVax for Adjuvant Melanoma Immunotherapy
Mabwell's MAIWEIJIAN Denosumab Injection Receives NMPA Acceptance for Expanded Cancer Bone Complications Treatment
Mabwell's LILRB4/CD3 Bispecific Antibody 6MW5311 Receives NMPA IND Approval for Leukemia Treatment
Mabwell's MAIWEIJIAN Denosumab Gets NMPA Acceptance for Expanded Cancer Bone Treatment
Dogwood Therapeutics SP16 Gets FDA IND Approval for Chemotherapy-Induced Pain Treatment